TGT
48
-2
CMCSA
46
-2
CB
58
-2
PX
55
2
RHI
52
2
UHS
54
-4
ORLY
62
-2
CTSH
57
-5
PNW
66
-3
AMG
41
3
ISRG
67
-4
AVGO
40
-24
QRVO
36
-4
EMC
45
3
C
54
4
BF.B
50
-3
EXPD
54
7
CF
57
3
CAH
54
-4
NAVI
57
2
TGT
48
-2
CMCSA
46
-2
CB
58
-2
PX
55
2
RHI
52
2
UHS
54
-4
ORLY
62
-2
CTSH
57
-5
PNW
66
-3
AMG
41
3
ISRG
67
-4
AVGO
40
-24
QRVO
36
-4
EMC
45
3
C
54
4
BF.B
50
-3
EXPD
54
7
CF
57
3
CAH
54
-4
NAVI
57
2
Financhill
Back

Pieris Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
31

PIRS
Pieris Pharmaceuticals

Last Price:
16.16
Seasonality Move:
-22.78%
Sell
29

NBY
NovaBay Pharmaceuticals

Last Price:
0.51
Seasonality Move:
-14.79%
Sell
31
Pieris Pharmaceuticals (PIRS) is a Sell

Is Pieris Pharmaceuticals a Buy, Sell or Hold?

  • The current Pieris Pharmaceuticals [PIRS] share price is $16.56. The Score for PIRS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • PIRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PIRS Stock Price Chart

What is Pieris Pharmaceuticals's stock price today?

  • The Pieris Pharmaceuticals share price today is $16.56
    The current trend is moderately bearish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PIRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.36 Buy
Relative Strength Index (14 RSI): 49.21 Sell
Chaikin Money Flow: -2064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.65 - 17.99) Sell
Bollinger Bands (100): (8.81 - 16.31) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 40.27 Sell
Chaikin Money Flow: 161961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Buy
Bollinger Bands (100): (0.64 - 3.4) Sell

PIRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.02 Sell
20-day SMA: 17.5 Sell
50-day SMA: 14.85 Buy
200-day SMA: 13.2 Buy
8-day EMA: 16.96 Sell
20-day EMA: 16.97 Sell
50-day EMA: 15.45 Buy
200-day EMA: 17.98 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.48 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.93 Sell
200-day SMA: 3.89 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.99 Sell
200-day EMA: 8.5 Sell

Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $8.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Pieris Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):